FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and relates to disturbed salivation. A composition containing sialic acid for treating or preventing the diseases related to disturbed salivation contains a protein fraction containing 7 to 25 wt % of N-acetylneuraminic acid and threonine in the amount of 8 to 22% of total amino acids, wherein N-acetylneuraminic acid is bound to a threonine-enriched peptide-protein network.
EFFECT: invention enables increasing salivation, especially observed in elderly persons and accompanying such diseases as dysphagia, xerostomia and a combination thereof.
23 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SIALIC ACID FOR BOLSTERING IMMUNE SYSTEM IN ELDERLY AGE | 2009 |
|
RU2506087C2 |
| OLIGOSACCHARIDE INGREDIENT | 2009 |
|
RU2497827C2 |
| OLIGOSACCHARIDE INGREDIENT | 2009 |
|
RU2496782C2 |
| BACTERIA, PRODUCING SIALIC ACID | 2009 |
|
RU2522136C2 |
| METHOD FOR TEACHEABILITY AND MEMORY IMPROVEMENT IN MAMMALS | 2006 |
|
RU2396975C2 |
| LACTOFERRIN AND NEURONAL HEALTH AND DEVELOPING INTESTINE IN INFANTS | 2010 |
|
RU2552328C2 |
| LACTOFERRIN AND DEVELOPMENT OF HEALTHY BRAIN IN BABIES | 2010 |
|
RU2568596C2 |
| LACTOFERRIN AND HEALTHY BRAIN DEVELOPING IN INFANTS | 2010 |
|
RU2688671C2 |
| COMPOSITION FOR USE IN PROMOTION OF MAGNESIUM ABSORPTION AND/OR MAGNESIUM RETENTION | 2012 |
|
RU2604502C2 |
| PREBIOTICS FOR REDUCING RISK OF DEVELOPING OBESITY IN LATER LIFE | 2015 |
|
RU2699981C2 |
